Observing brain health in adults with late-onset epilepsy
Official title: A Prospective Population-based Longitudinal Observational Cohort Study of Late-onset Epilepsy, and Subsequent Stroke and Dementia.
Run by Lancashire Teaching Hospitals NHS Foundation Trust · NCT06263920 · Data updated 2026-11-12
This study is trying to see how having late-onset epilepsy affects brain health and the risk of conditions like stroke or dementia in adults who have their first seizure after age 18.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 360 (estimated) |
| Sponsor | Lancashire Teaching Hospitals NHS Foundation Trust Academic / other |
| Locations | 1 site (Preston, Lancashire) |
| Status | Recruiting |
| Started | May 5, 2022 |
| Main results expected | January 12, 2027 |
| Study ends | January 12, 2027 |
| Registry record updated | April 8, 2025 |
| Trial ID | NCT06263920 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults who have been diagnosed with late-onset epilepsy or experienced their first seizure after the age of 18.
✕Probably not a fit
Patients with seizures attributable to identifiable causes such as malignancy or stroke are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The NeuroFrailty study aims to investigate the long-term effects of late-onset epilepsy by observing individuals who experience their first seizure after the age of 18. Participants will undergo various assessments, including blood tests, brain scans, and lifestyle evaluations, to track changes in memory, health, and potential new diagnoses over several years. The study seeks to determine if there is a connection between late-onset epilepsy and the risk of developing conditions such as stroke or dementia. By comparing these individuals to those without seizures, the research hopes to shed light on the implications of adult-onset epilepsy.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the long-term health risks associated with late-onset epilepsy, potentially leading to better management and preventive strategies for affected patients.
How similar studies have gone: While there is limited research in this specific area, the study's observational approach is novel and aims to fill a significant gap in understanding the relationship between late-onset epilepsy and other neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion criteria for case participants includes: * diagnosis of LOE or first seizure after the age of 18. * diagnosis confirmed or established at a tertiary neurology centre. * sequential cases will be used; in the unlikely event that eligible cases outstrip capacity, an annual cap of the first 150 patients per year per cohort will be used. Inclusion criteria for control participants includes: * established diagnosis of migraine. * with or without therapeutic medications with antiepileptic properties. Exclusion Criteria Exclusion criteria for case participants includes: * a 'lesional' attributable cause for seizures including malignancy, stroke (excluding transient ischaemic attack), hypoxic brain injury, trauma, vascular or congenital abnormality of likely aetiological significance. * people with migraine or headache syndrome can be included in case group - the presence or absence of a seizure syndrome is mutually exclusive between case and control groups, not the presence or absence of migraine. Exclusion criteria for control participants includes: * diagnosis of epilepsy or confirmed seizure. * 'lesional' attributable cause for seizures including malignancy, stroke (excluding transient ischaemic attack), hypoxic brain injury, trauma.
Where it's running
-
Lancashire Teaching Hospitals NHS
Preston, Lancashire, United Kingdom Recruiting
Study contacts
- Principal investigator: Jasmine Wall, MB BChir — University of Lancaster
- Study coordinator: Jasmine Wall, MB BChir
- Email: jasmine.wall@lthtr.nhs.uk
- Phone: via switchboard
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Investigation of disabilities following stroke in Taiwan
This study is looking at how many people have disabilities after a stroke and what might cause them, by following 2,000 stroke patients in Taiwan over a year.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
Exploring brain blood flow and function in stroke, depression, dementia, and delirium
This study is trying to see how different imaging techniques can help us understand blood flow in the brain of people with stroke, depression, dementia, and delirium, as well as healthy individuals.
-
Fighting cognitive decline and dementia caused by small vessel disease
This study is trying to see how changes in the brain and eye blood vessels can help predict dementia risk in people over 60 with small vessel disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.